Publications found:
260,034
Sort by:
The Roche Intelligence Dossier
US$ 295.00
As the fourth largest pharmaceutical company in the world, with annual revenues of $43.9 billion, some of the most instantly recognisable drugs marketed and the kind of pipeline smaller companies only...
November 2009
48 pages
The GSK Intelligence Dossier
US$ 295.00
After two anemic years, GSK is ready to breathe new life.Despite intense competition from generics in the US, the company has finally reported a healthy growth in the third quarter of 2009.Now, eager...
November 2009
53 pages
The Novartis Intelligence Dossier
US$ 295.00
International censure over Novartis’ grave delays in supplying the H1N1 vaccine.Renewed criticism by an institutional investor for CEO Daniel Vasella’s substantial pay package and considerable power.A...
November 2009
55 pages
The Value of a Good Reputation in Pharma
US$ 795.00
“It takes many good deeds to build a good reputation,” Benjamin Franklin once wisely observed, “and only one bad one to lose it.”How many good deeds will it take to repair the pharmaceutical industry’...
November 2009
40 pages
Asia Pacific Market for Bone Graft Substitutes and Other Biomaterials 2009 (3 Countries)
US$ 8,495.00
... includes Japan, South Korea, and Australia. In 2008, the combined Asia-Pacific market for dental bone graft substitutes (BGS) and other biomaterials was ... account for an unusually large percentage of dental BGS materials used in the Asia-Pacific region because allograft and xenograft products are not approved ...
November 2009
200 pages
Opportunity Analysis of H1N1 (swine flu) Vaccination Market
US$ 5,650.00
... and forecast This report will enable strategic understanding and opportunities in the H1N1 2009 influenza vaccines market. The report covers the ... positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders. - Comprehensive market analysis for the following sectors: ...
November 2009
126 pages
Global Stem Cell and Advanced Technologies Market
US$ 5,650.00
... the global stem cell market as follows: • Stem Cell Products (adult stem cell, human embryonic stem cell, and other stem cell types) • Stem Cell Services (stem cell banking, stem cell ... and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We ...
November 2009
229 pages
Competitor Analysis: FGF-R Agonists and Antagonists
US$ 360.00
Product description The present Competitive Intelligence Report about FGF-R agonists and antagonists provides a competitor evaluation in the field of fibroblast growth factor receptor (FGF-R) or PDGF targeting molecules for wound healing, cardiac tissue repair, bone formation or treatment of cancer as of ...
November 2009
37 pages
Competitor Analysis: Proteasome Inhibitors
US$ 120.00
... R&D Stage and additional comments with a hyperlink leading to the source of information. Index Velcade Pipeline Proteasome Inhibitors Corporate Proteasome Inhibitor R&D Pipelines About La Merie About Competitor Analysis Series The Competitor Analysis Series delivers NO-FRILLS , but concise ...
November 2009
14 pages
Competitor Analysis: CXCR and CXCL Agonists and Antagonists
US$ 360.00
... The present Competitive Intelligence Report about CXCR agonists and CXCR/CXCL antagonists provides a competitor evaluation in the field of chemokine receptor ... approved and marketed drug is plerixafor (AMD3100), a small molecule inhibitor of the CXCR-4/SDF-1 axis, used for stem cell mobilization. CXCR1 and ...
November 2009
30 pages
Veterinary Diagnostics Markets
US$ 995.00
Diagnostic tests are an essential tool for confirming the health status of animals. The global impact of diseases such as bovine spongiform encephalopathy, foot and mouth disease, and highly pathogeni...
October 2009
30 pages
Conference Intelligence Dossier: EASD Annual Meeting 2009
US$ 995.00
The numbers are staggering: More than 200 million people around the world now suffer from diabetes and its major complications. According to the World Health Organization, that figure is expected to s...
October 2009
90 pages
The Pfizer Intelligence Dossier
US$ 295.00
In boardrooms, around water coolers and behind closed office doors, decision-makers in the pharmaceutical industry are asking questions: What’s happening with Pfizer? What developments have occurred i...
October 2009
60 pages
Pharma Sales Forces: Change in the Face of Adversity
US$ 395.00
“Change,” futurist Alvin Toffler once said, “is the process by which the future invades our lives.” For the pharmaceutical sales industry, that future is unfolding now. Dropping revenue, increasingly...
October 2009
40 pages
European Markets for Interventional Cardiology 2009 (15 Countries)
US$ 11,495.00
... 2008, the European market for interventional cardiology was valued at over €1.5 billion. The interventional cardiology market includes drug-eluting stents, ... devices, and IVUS catheters. In addition, this report covers the emerging markets for optical coherence tomography (OCT), vulnerable plaque screening, PFO ...
October 2009
409 pages
Japanese Market for Women's Health Devices 2009
US$ 7,495.00
... for women’s health devices was valued at over $234 million. Over 40% of the Japanese market for women’s health devices was accounted for by OB/GYN ultrasound imaging alone. The market for women’s health includes the segments and sub-segments for bone densitometry, breast biopsy, ...
October 2009
250 pages
European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries)
US$ 7,495.00
The European market, as defined in this report, encompasses Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands, and Luxemburg), Scandinavia (Finland, Denmark, Sweden, and Norway), Portugal, Austria, and Switzerland. Additional products included in this report: ...
October 2009
102 pages
Global Markets for Assisted Reproduction Devices 2010
US$ 11,495.00
Global Markets for Assisted Reproduction covers the U.S., 15 Countries in Europe and Japan. This report includes the Oocyte Retrieval Needle Market, Embryo Transfer Catheter Market and the Reproductive Media Market. The report includes procedure numbers, market forecasts and ...
October 2009
150 pages
Future of Green Biotechnology in China
US$ 9,683.00
... mentioned above are summarized specifically. - Overview of China’s green biotechnology: A higher level analysis and summary - Future ... in market, R&D and applications of China’s green biotechnology - Discover the potential opportunities for green biotechnology in China - Benefit from a thorough review of ...
October 2009
131 pages
Dental Eqquipment Growth in International Dental Industry
US$ 450.00
The present report on Dental Industry focuses on dental equipment market in United States also discusses markets in Europe and Asia. It gives an overview of the worldwide dental industry and its segme...
September 2009
32 pages
European Markets for Enteral Feeding Devices 2009 (Germany, France, U.K, Italy, Spain)
US$ 11,495.00
... market will reach €62.2 million by 2015. The market for enteral feeding devices in Europe is driven both by the very young and the elderly patient ... This trend is especially prevalent in France. This contributes the stability of the market, as the demand for the devices is distributed among different patient ...
September 2009
130 pages
European Markets for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 11,495.00
In 2008, the combined European market for dental bone graft substitutes and other biomaterials increased by 12.9% over 2007. The European market includes Austria, Benelux, France, Germany, Israel, Italy, Poland, Portugal, Scandinavia, Spain, Switzerland and ...
September 2009
545 pages
Austrian Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
In 2008, the Austrian market for dental bone graft substitutes grew by double digit rates. The 2008 average selling price was similar to the European average and can be expected to increase over the forecast period. Future growth will be driven by an increasing number of implant ...
September 2009
70 pages
Beneluxian Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
The Beneluxian market for dental bone graft substitutes and other biomaterials, which includes Belgium, the Netherlands and Luxemburg, was the seventh largest in Europe in 2008. The Netherlands represented the vast majority of this market, which grew significantly in 2007. The rapid growth in the number of ...
September 2009
70 pages
French Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
In 2008, the French market for dental bone graft substitutes was the fourth largest in Europe. The 2008 average selling price for dental ... higher material costs and a lack of government and private insurance coverage. The French market will continue to see double digit growth driven by an increasing number of ...
September 2009
70 pages
Polish Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
The Polish market for dental bone graft substitutes and other biomaterials was the ninth largest in Europe. In 2008, growth in the number of ... implant procedures well into double digit rates over the forecast period. Poland is also associated with greater use of mineralized allografts, bolstered by demand for ...
September 2009
70 pages
Swiss Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
In 2008, the Swiss market for dental bone graft substitutes and other biomaterials grew at double digit rates. While Switzerland has a relatively small population, it has one of the highest dental implant per capita rates in Europe, driving bone graft substitute use. ...
September 2009
70 pages
U.K. Market for Dental Bone Graft Substitutes and Other Biomaterials 2009
US$ 4,495.00
The U.K. market for dental bone graft substitutes and other biomaterials was the sixth largest in Europe in 2008. The market growth rate is predicted to be well above the European average over the forecast period. Average selling prices for dental bone ...
September 2009
70 pages
European Markets for Dental Dental Growth Factors 2009
US$ 4,495.00
The European markets for dental growth factors include the markets for emdogain, in addition to the markets for potential dental growth factors such as GEM-21S and INFUSE and Platelet Rich Plasma (PRP)
September 2009
69 pages
Global Markets for Breast Biopsy Devices 2009
US$ 11,495.00
The global markets for breast biopsy devices includes the spring loaded core needle market and vacuum assisted breast biopsy (VABB) market. The countries covered in this report include the U.S., Austria, Belgium, Denmark, France, Finland, Germany, Italy, Luxemburg, ...
September 2009
115 pages
Global Biomaterial Market (2009-2014)
US$ 5,650.00
... global biomaterial market as follows: Biomaterials product market Orthopaedic, cardiovascular, gastrointestinal, wound care, plastic surgery, urological and others Biomaterials ingredient market Metals, polymers, ceramics, composites Biomaterials application market ...
September 2009
256 pages
Minimal Invasive and Non Invasive Product and Service Market (2009 - 2014)
US$ 5,650.00
... -edge medical technologies. This report uses the term ‘minimally invasive surgery’ to include non-invasive surgeries as well. The increasing demand of specialized treatment has ... report provides in-depth market estimates and forecast for global minimally invasive/non-invasive market as follows: • MIS market – products Surgical devices, monitoring and ...
September 2009
179 pages
Neurostimulation - Advanced Technologies and Global Market (2009 - 2014)
US$ 5,650.00
... from standard drug and invasive surgical therapy. The neurostimulation market is driven mainly by technology advancements, rising consumer awareness, rising age-related neurological ... -invasive stimulation technology ) The market data consists of aggregate sales figures of all neurostimulation submarkets. It analyzes the market aspects of new neurostimulation technologies and product ...
September 2009
107 pages
